PROBION
PROBION, licence 80130752: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Phytogenics Inc.
- NPN or DIN-HM
- 80130752
- Status
- Active licence
- Licence date
- 23 April 2024
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactobacillus delbrueckii subsp. bulgaricus | 0.75 Milliards d'UFC | Not calculated |
| Lacticaseibacillus Rhamnosus | 0.75 Milliards d'UFC | Not calculated |
| Lactococcus lactis Source : Lactococcus lactis - Cellule entière | 0.75 Milliards d'UFC | Not calculated |
| Lactobacillus acidophilus Source : Lactobacillus acidophilus - Cellule entière | 3.0 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : Lactiplantibacillus Plantarum - Cellule entière | 1.75 Milliards d'UFC | Not calculated |
| Lacticaseibacillus paracasei | 0.75 Milliards d'UFC | Not calculated |
| Bifidobacterium bifidum Source : Bifidobacterium bifidum - Cellule entière | 0.75 Milliards d'UFC | Not calculated |
| Levilactobacillus Brevis | 0.5 Milliards d'UFC | Not calculated |
| Limosilactobacillus Reuteri | 0.5 Milliards d'UFC | Not calculated |
| Ligilactobacillus salivarius | 0.5 Milliards d'UFC | Not calculated |
| Bifidobacterium longum subsp. longum Source : Bifidobacterium longum subsp. longum - Cellule entière | 0.5 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Gomme de gellane, Stéarate de magnésium, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 ans | 1.0 Capsule | 1.0 Tous les jours |
| Enfants | minimum: 6.0 ans ; maximum: 11.0 ans | 1.0 Capsule | 1.0 Tous les jours |
| Adolescentes | minimum: 12.0 ans ; maximum: 17.0 ans | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80130752
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.